240 related articles for article (PubMed ID: 25053826)
1. BRCA2 and RAD51 promote double-strand break formation and cell death in response to gemcitabine.
Jones RM; Kotsantis P; Stewart GS; Groth P; Petermann E
Mol Cancer Ther; 2014 Oct; 13(10):2412-21. PubMed ID: 25053826
[TBL] [Abstract][Full Text] [Related]
2. Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.
Kim TM; Son MY; Dodds S; Hu L; Hasty P
Mutat Res; 2014; 766-767():66-72. PubMed ID: 25847274
[TBL] [Abstract][Full Text] [Related]
3. Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.
Kim TM; Son MY; Dodds S; Hu L; Hasty P
Mutat Res; 2014; 766-767():66-72. PubMed ID: 25773776
[TBL] [Abstract][Full Text] [Related]
4. Rad51 recruitment and exclusion of non-homologous end joining during homologous recombination at a Tus/Ter mammalian replication fork barrier.
Willis NA; Panday A; Duffey EE; Scully R
PLoS Genet; 2018 Jul; 14(7):e1007486. PubMed ID: 30024881
[TBL] [Abstract][Full Text] [Related]
5. RADX Promotes Genome Stability and Modulates Chemosensitivity by Regulating RAD51 at Replication Forks.
Dungrawala H; Bhat KP; Le Meur R; Chazin WJ; Ding X; Sharan SK; Wessel SR; Sathe AA; Zhao R; Cortez D
Mol Cell; 2017 Aug; 67(3):374-386.e5. PubMed ID: 28735897
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
[TBL] [Abstract][Full Text] [Related]
7. Brca2, Rad51 and Mre11: performing balancing acts on replication forks.
Costanzo V
DNA Repair (Amst); 2011 Oct; 10(10):1060-5. PubMed ID: 21900052
[TBL] [Abstract][Full Text] [Related]
8. Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments.
Kolinjivadi AM; Sannino V; De Antoni A; Zadorozhny K; Kilkenny M; Técher H; Baldi G; Shen R; Ciccia A; Pellegrini L; Krejci L; Costanzo V
Mol Cell; 2017 Sep; 67(5):867-881.e7. PubMed ID: 28757209
[TBL] [Abstract][Full Text] [Related]
9. Homologous recombination deficiency real-time clinical assays, ready or not?
Fuh K; Mullen M; Blachut B; Stover E; Konstantinopoulos P; Liu J; Matulonis U; Khabele D; Mosammaparast N; Vindigni A
Gynecol Oncol; 2020 Dec; 159(3):877-886. PubMed ID: 32967790
[TBL] [Abstract][Full Text] [Related]
10. A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells.
Bhattacharjee V; Zhou Y; Yen TJ
Cell Cycle; 2014; 13(24):3839-56. PubMed ID: 25558828
[TBL] [Abstract][Full Text] [Related]
11. The BRCA2 and CDKN1A-interacting protein (BCCIP) stabilizes stalled replication forks and prevents degradation of nascent DNA.
Singh B; Roy Chowdhury S; Mansuri MS; Pillai SJ; Mehrotra S
FEBS Lett; 2022 Aug; 596(16):2041-2055. PubMed ID: 35592921
[TBL] [Abstract][Full Text] [Related]
12. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.
Luo K; Li L; Li Y; Wu C; Yin Y; Chen Y; Deng M; Nowsheen S; Yuan J; Lou Z
Genes Dev; 2016 Dec; 30(23):2581-2595. PubMed ID: 27941124
[TBL] [Abstract][Full Text] [Related]
13. Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibition.
Lodhia KA; Gao S; Aleksic T; Esashi F; Macaulay VM
Int J Cancer; 2015 Jun; 136(12):2961-6. PubMed ID: 25388513
[TBL] [Abstract][Full Text] [Related]
14. Moonlighting at replication forks - a new life for homologous recombination proteins BRCA1, BRCA2 and RAD51.
Kolinjivadi AM; Sannino V; de Antoni A; Técher H; Baldi G; Costanzo V
FEBS Lett; 2017 Apr; 591(8):1083-1100. PubMed ID: 28079255
[TBL] [Abstract][Full Text] [Related]
15. ATP-dependent nucleosome unwrapping catalyzed by human RAD51.
North JA; Amunugama R; Klajner M; Bruns AN; Poirier MG; Fishel R
Nucleic Acids Res; 2013 Aug; 41(15):7302-12. PubMed ID: 23757189
[TBL] [Abstract][Full Text] [Related]
16. A Short BRCA2-Derived Cell-Penetrating Peptide Targets RAD51 Function and Confers Hypersensitivity toward PARP Inhibition.
Trenner A; Godau J; Sartori AA
Mol Cancer Ther; 2018 Jul; 17(7):1392-1404. PubMed ID: 29654063
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication.
Fridlich R; Annamalai D; Roy R; Bernheim G; Powell SN
DNA Repair (Amst); 2015 Jun; 30():11-20. PubMed ID: 25836596
[TBL] [Abstract][Full Text] [Related]
18. Double-stranded DNA binding function of RAD51 in DNA protection and its regulation by BRCA2.
Halder S; Sanchez A; Ranjha L; Reginato G; Ceppi I; Acharya A; Anand R; Cejka P
Mol Cell; 2022 Oct; 82(19):3553-3565.e5. PubMed ID: 36070766
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair.
Petermann E; Orta ML; Issaeva N; Schultz N; Helleday T
Mol Cell; 2010 Feb; 37(4):492-502. PubMed ID: 20188668
[TBL] [Abstract][Full Text] [Related]
20. Rad18 is required for functional interactions between FANCD2, BRCA2, and Rad51 to repair DNA topoisomerase 1-poisons induced lesions and promote fork recovery.
Tripathi K; Mani C; Clark DW; Palle K
Oncotarget; 2016 Mar; 7(11):12537-53. PubMed ID: 26871286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
